Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02641093 |
Title | Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Trisha Wise-Draper |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Louisville - James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | United States | Details | |
Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
Medical University of South Carolina | Charleston | South Carolina | 29425 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |